搜尋結果
2024年1月23日 · Multiply total daily dose of prior opioid by the conversion factor (CF) provided below to obtain oxycodone dose in mg/day; divide oxycodone mg/day dose by 2 to get 12-hour oxycodone ER dose; if rounding is necessary, always round down to the nearest tablet strength available.
2024年3月22日 · Risperidone is an antipsychotic medicine that works by changing the effects of chemicals in the brain. Risperidone is used to treat schizophrenia in adults and children who are at least 13 years old. Risperidone is also used to treat symptoms of bipolar disorder (manic depression) in adults and children who are at least 10 years old.
- (673)
- Medical Doctor
Some side effects of semaglutide may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
2023年10月29日 · Generic name: amlodipine [ am-LOE-di-peen ] Brand names: Katerzia, Norliqva, Norvasc. Dosage forms: oral tablet 5 mg, 10mg, 2.5 mg, oral liquid 1 mg/mL, oral suspension 1 mg/mL. Drug class: Calcium channel blockers. Medically reviewed by Melisa Puckey, BPharm. Last updated on Oct 29, 2023. Uses.
Ecstasy (MDMA, 3,4 methylenedioxymethamphetamine), also commonly called Molly, is a synthetic (lab made), psychoactive drug chemically similar to the stimulant methamphetamine and the hallucinogen mescaline.
2023年11月22日 · What is Cymbalta? Cymbalta is a selective serotonin and norepinephrine reuptake inhibitor antidepressant (SSNRI). Duloxetine affects chemicals in the brain that may be unbalanced in people with depression. Cymbalta is used to treat major depressive disorder in adults.
The following drugs have recently been approved by the FDA. Includes newly approved drugs and new indications for drugs already approved. See also: Generic approvals, Approval process, New indications & dosage forms. Pyzchiva (ustekinumab-ttwe) Injection. Company: Samsung Bioepis Co., Ltd. Date of Approval: June 28, 2024.
